Moral bioenhancement, freedom and reasoning

This issue includes a number of papers on reproductive ethics, broadly construed. In a recent book, Anja Karnein proposed that embryos created in vitro should be offered up for adoption before being discarded or used in research;1 here Timothy Murphy offers a critical response (see page 392). Elsewh...

Full description

Saved in:  
Bibliographic Details
Main Author: Douglas, Thomas (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2014
In: Journal of medical ethics
Year: 2014, Volume: 40, Issue: 6, Pages: 359-360
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)
Description
Summary:This issue includes a number of papers on reproductive ethics, broadly construed. In a recent book, Anja Karnein proposed that embryos created in vitro should be offered up for adoption before being discarded or used in research;1 here Timothy Murphy offers a critical response (see page 392). Elsewhere, Tak Chan and Stark & Delatycki debate the role of medical professionals in providing parentage determination. Chan argues that doctors are obliged to provide parentage tests when this is requested by parents, provided there is a low risk that the child will be abandoned (see page 383). Stark & Delatycki discuss some difficulties raised by the ‘risk of abandonment’ condition (see page 387). Finally, papers by Kate Greasley and David Lang discuss the controversy surrounding the criminal prosecution of abortion doctor Kermit Gosnell. Greasley criticises the way in which some commentators capitalised on horror at Gosnell's extreme practices to advance more general anti-abortion objectives (see page 419). Lang argues, against Greasley, that the dominant pro-life response to the case was neither self-contradictory nor intellectually dishonest (see page 424). The issue is dominated, however, by discussions of ‘bioenhancement’ - the use of biomedical technologies to augment human capacities. A common criticism of bioenhancements is that they are anti-social: though they may benefit the user, they will have a negative effect on society-at-large. Such concerns are perhaps well placed in relation to the most obvious contemporary examples of bioenhancement: doping in sport, aesthetic medicine, and the use of stimulants to enhance examination performance. However, two varieties of bioenhancement discussed in this issue might be thought to have more positive social effects. David Shaw discusses the possible use of cognitive enhancing drugs to improve health outcomes in disadvantaged segments of society (see page 389). Such enhancements might be thought to have desirable social …
ISSN:1473-4257
Contains:Enthalten in: Journal of medical ethics
Persistent identifiers:DOI: 10.1136/medethics-2014-102214